LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | GSK1904529A | 0.12 | uM | LJP6 | 1 | H23 | 72 | hr | 1389 | 3373 | 5147 | 0.6553 | 0.5992 |
MCF7 | GSK1904529A | 0.12 | uM | LJP6 | 2 | H23 | 72 | hr | 1389 | 3496 | 5447 | 0.6417 | 0.5970 |
MCF7 | GSK1904529A | 0.12 | uM | LJP6 | 3 | H23 | 72 | hr | 1389 | 3349 | 5740 | 0.5834 | 0.5371 |
MCF7 | GSK1904529A | 0.37 | uM | LJP6 | 1 | H22 | 72 | hr | 1389 | 3051 | 5147 | 0.5928 | 0.5165 |
MCF7 | GSK1904529A | 0.37 | uM | LJP6 | 2 | H22 | 72 | hr | 1389 | 2950 | 5447 | 0.5415 | 0.4652 |
MCF7 | GSK1904529A | 0.37 | uM | LJP6 | 3 | H22 | 72 | hr | 1389 | 3227 | 5740 | 0.5622 | 0.5095 |
MCF7 | GSK1904529A | 1.11 | uM | LJP6 | 1 | H21 | 72 | hr | 1389 | 2731 | 5147 | 0.5306 | 0.4301 |
MCF7 | GSK1904529A | 1.11 | uM | LJP6 | 2 | H21 | 72 | hr | 1389 | 3078 | 5447 | 0.5650 | 0.4971 |
MCF7 | GSK1904529A | 1.11 | uM | LJP6 | 3 | H21 | 72 | hr | 1389 | 2827 | 5740 | 0.4925 | 0.4150 |
MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 1 | H20 | 72 | hr | 1389 | 2814 | 5147 | 0.5467 | 0.4530 |
MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 2 | H20 | 72 | hr | 1389 | 2706 | 5447 | 0.4967 | 0.4025 |
MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 3 | H20 | 72 | hr | 1389 | 2967 | 5740 | 0.5169 | 0.4488 |
MCF7 | GSK1904529A | 10 | uM | LJP6 | 1 | H19 | 72 | hr | 1389 | 2513 | 5147 | 0.4882 | 0.3685 |
MCF7 | GSK1904529A | 10 | uM | LJP6 | 2 | H19 | 72 | hr | 1389 | 2797 | 5447 | 0.5134 | 0.4262 |
MCF7 | GSK1904529A | 10 | uM | LJP6 | 3 | H19 | 72 | hr | 1389 | 2787 | 5740 | 0.4855 | 0.4052 |
MCF7 | Linsitinib | 0.04 | uM | LJP5 | 1 | O24 | 72 | hr | 1389 | 3984 | 5772 | 0.6902 | 0.6698 |
MCF7 | Linsitinib | 0.04 | uM | LJP5 | 3 | O24 | 72 | hr | 1389 | 4598 | 6038 | 0.7615 | 0.7587 |
MCF7 | Linsitinib | 0.12 | uM | LJP5 | 1 | O23 | 72 | hr | 1389 | 5251 | 5772 | 0.9097 | 0.9099 |
MCF7 | Linsitinib | 0.12 | uM | LJP5 | 3 | O23 | 72 | hr | 1389 | 5046 | 6038 | 0.8356 | 0.8376 |
MCF7 | Linsitinib | 0.37 | uM | LJP5 | 1 | O22 | 72 | hr | 1389 | 4279 | 5772 | 0.7413 | 0.7289 |
MCF7 | Linsitinib | 0.37 | uM | LJP5 | 3 | O22 | 72 | hr | 1389 | 4933 | 6038 | 0.8169 | 0.8181 |
MCF7 | Linsitinib | 1.11 | uM | LJP5 | 1 | O21 | 72 | hr | 1389 | 3602 | 5772 | 0.6240 | 0.5899 |
MCF7 | Linsitinib | 1.11 | uM | LJP5 | 3 | O21 | 72 | hr | 1389 | 3892 | 6038 | 0.6445 | 0.6258 |
MCF7 | Linsitinib | 3.33 | uM | LJP5 | 1 | O20 | 72 | hr | 1389 | 3092 | 5772 | 0.5356 | 0.4761 |
MCF7 | Linsitinib | 3.33 | uM | LJP5 | 3 | O20 | 72 | hr | 1389 | 3194 | 6038 | 0.5289 | 0.4810 |